Literature DB >> 19876673

Cognitive behavioural treatment of negative symptoms in schizophrenia patients: study design of the TONES study, feasibility and safety of treatment.

Stefan Klingberg1, Andreas Wittorf, Jutta Herrlich, Georg Wiedemann, Christoph Meisner, Gerhard Buchkremer, Nicole Frommann, Wolfgang Wölwer.   

Abstract

Currently, there are no convincing treatment strategies for negative symptoms of schizophrenia. On this background, we are conducting the treatment of negative symptoms (TONES) study which addresses the question whether cognitive behavioural therapy (CBT) is efficacious for the reduction of negative symptoms in schizophrenia. The present paper aims at presenting the design of the clinical trial of the study as well as the treatment concept. Further, we investigate the feasibility and the safety of our study treatment. The TONES study is a multicentric, prospective, single-blind, randomised, and controlled trial (RCT). The clinical trial compares CBT (test condition) and cognitive remediation (CR; control condition) with respect to the efficacy in reducing negative symptoms. In order to systematically assess aspects of adherence and feasibility therapists filled in session reports after each session. The safety analysis is performed using the sequential method of Whitehead (The design and analysis of sequential clinical trials, Ellis Horwood, Chichester, 1983). We were able to conduct a systematic recruitment and to include a sample of N = 198 patients which is characterised by negative symptoms of medium severity. The majority of patients accepted the format of a 50-min treatment session. The manualised treatment content seemed to be adequate and the cooperation between patients and therapists was excellent or adequate in approximately 80% of the treatment sessions. Of the 15 severe adverse events 10 occurred in the CBT and 5 in the CR. This difference between the groups was not significant. The study presented here is presumably the first high quality RCT which evaluates CBT with negative symptoms as primary endpoint. On the background of the data presented we conclude that CBT for the reduction of negative symptoms is feasible and can be conducted safely.

Entities:  

Mesh:

Year:  2009        PMID: 19876673     DOI: 10.1007/s00406-009-0047-8

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  18 in total

1.  A meta-analysis of the efficacy of second-generation antipsychotics.

Authors:  John M Davis; Nancy Chen; Ira D Glick
Journal:  Arch Gen Psychiatry       Date:  2003-06

Review 2.  Supportive therapy for schizophrenia: possible mechanisms and implications for adjunctive psychosocial treatments.

Authors:  David L Penn; Kim T Mueser; Nick Tarrier; Andrew Gloege; Corrine Cather; Daniel Serrano; Michael W Otto
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

Review 3.  Practice guideline for the treatment of patients with schizophrenia, second edition.

Authors:  Anthony F Lehman; Jeffrey A Lieberman; Lisa B Dixon; Thomas H McGlashan; Alexander L Miller; Diana O Perkins; Julie Kreyenbuhl
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

4.  A meta-analysis of cognitive remediation in schizophrenia.

Authors:  Susan R McGurk; Elizabeth W Twamley; David I Sitzer; Gregory J McHugo; Kim T Mueser
Journal:  Am J Psychiatry       Date:  2007-12       Impact factor: 18.112

5.  Longitudinal assessment of negative symptoms in schizophrenia/schizoaffective patients, other psychotic patients, and depressed patients.

Authors:  E S Herbener; M Harrow
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

6.  Remediation of impairments in facial affect recognition in schizophrenia: efficacy and specificity of a new training program.

Authors:  Wolfgang Wölwer; Nicole Frommann; Sabine Halfmann; Anja Piaszek; Marcus Streit; Wolfgang Gaebel
Journal:  Schizophr Res       Date:  2005-08-24       Impact factor: 4.939

7.  Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia.

Authors:  H Häfner; W Löffler; K Maurer; M Hambrecht; W an der Heiden
Journal:  Acta Psychiatr Scand       Date:  1999-08       Impact factor: 6.392

Review 8.  Cognitive behaviour therapy for schizophrenia.

Authors:  C Jones; I Cormac; J I Silveira da Mota Neto; C Campbell
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

9.  A group cognitive-behavioral and process-oriented approach to treating the social impairment and negative symptoms associated with chronic mental illness.

Authors:  L Daniels
Journal:  J Psychother Pract Res       Date:  1998

10.  Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT.

Authors:  Nicholas Tarrier; Gillian Haddock; Shon Lewis; Richard Drake; Lynsey Gregg
Journal:  Schizophr Res       Date:  2006-02-07       Impact factor: 4.939

View more
  13 in total

1.  Room to move: Plasticity in early auditory information processing and auditory learning in schizophrenia revealed by acute pharmacological challenge.

Authors:  Neal R Swerdlow; Savita G Bhakta; Gregory A Light
Journal:  Schizophr Res       Date:  2018-04-05       Impact factor: 4.939

Review 2.  Towards medication-enhancement of cognitive interventions in schizophrenia.

Authors:  Hsun-Hua Chou; Elizabeth Twamley; Neal R Swerdlow
Journal:  Handb Exp Pharmacol       Date:  2012

3.  Negative symptoms of schizophrenia as primary target of cognitive behavioral therapy: results of the randomized clinical TONES study.

Authors:  Stefan Klingberg; Wolfgang Wölwer; Corinna Engel; Andreas Wittorf; Jutta Herrlich; Christoph Meisner; Gerhard Buchkremer; Georg Wiedemann
Journal:  Schizophr Bull       Date:  2011-09       Impact factor: 9.306

4.  The Vicious Cycle of Family Atmosphere, Interpersonal Self-concepts, and Paranoia in Schizophrenia-A Longitudinal Study.

Authors:  Klaus Hesse; Levente Kriston; Stephanie Mehl; Andreas Wittorf; Wolfgang Wiedemann; Wolfgang Wölwer; Stefan Klingberg
Journal:  Schizophr Bull       Date:  2015-04-29       Impact factor: 9.306

5.  Are we studying and treating schizophrenia correctly?

Authors:  Neal R Swerdlow
Journal:  Schizophr Res       Date:  2011-06-08       Impact factor: 4.939

6.  Patient's trust in their psychiatrist: a cross-sectional survey.

Authors:  Atsumi Minamisawa; Takefumi Suzuki; Koichiro Watanabe; Yasushi Imasaka; Yoshie Kimura; Hiroyoshi Takeuchi; Shinichiro Nakajima; Haruo Kashima; Hiroyuki Uchida
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-03-03       Impact factor: 5.270

Review 7.  Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia.

Authors:  Christopher Jones; David Hacker; Irene Cormac; Alan Meaden; Claire B Irving
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

Review 8.  Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions.

Authors:  Ori Elis; Janelle M Caponigro; Ann M Kring
Journal:  Clin Psychol Rev       Date:  2013-07-16

9.  Cognitive behavioural therapy plus standard care versus standard care for people with schizophrenia.

Authors:  Christopher Jones; David Hacker; Jun Xia; Alan Meaden; Claire B Irving; Sai Zhao; Jue Chen; Chunhu Shi
Journal:  Cochrane Database Syst Rev       Date:  2018-12-20

10.  Cognitive behavioural therapy plus standard care versus standard care plus other psychosocial treatments for people with schizophrenia.

Authors:  Christopher Jones; David Hacker; Alan Meaden; Irene Cormac; Claire B Irving; Jun Xia; Sai Zhao; Chunhu Shi; Jue Chen
Journal:  Cochrane Database Syst Rev       Date:  2018-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.